OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a study to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) compared with placebo, in achieving a 100% reduction in urinary incontinence in patients with overactive bladder (OAB) not properly managed with an anticholinergic.
Epistemonikos ID: b312af0761eee00112097b7cd2a084db69152f69
First added on: May 11, 2024